Page last updated: 2024-09-03

parecoxib and acetylsalicylic acid lysinate

parecoxib has been researched along with acetylsalicylic acid lysinate in 1 studies

Compound Research Comparison

Studies
(parecoxib)
Trials
(parecoxib)
Recent Studies (post-2010)
(parecoxib)
Studies
(acetylsalicylic acid lysinate)
Trials
(acetylsalicylic acid lysinate)
Recent Studies (post-2010) (acetylsalicylic acid lysinate)
4361862293269126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bulut, D; Hanefeld, C; Koll, R; Liaghat, S; Miebach, T; Mügge, A1

Trials

1 trial(s) available for parecoxib and acetylsalicylic acid lysinate

ArticleYear
Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension.
    Journal of hypertension, 2003, Volume: 21, Issue:9

    Topics: Acetylcholine; Adult; Aged; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Isoenzymes; Isoxazoles; Lysine; Male; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Regional Blood Flow; Vasodilation; Vasodilator Agents

2003